Thursday, April, 18, 2019 08:44:51
FDA prohibits Coloplast, Boston Scientific from selling surgical mesh
MediciNova plans to move ahead with phase-3 trial of MN-166 in ALS
Dr. Reddy’s Laboratories acquires 42 ANDAs portfolio in the U.S.
Catalent Inc to acquire Paragon Bioservices in a $1.2 billion deal
Your Name (required)
Your Email (required)